Cell and gene therapy hold tremendous promise for treating a wide array of diseases, including many that were previously considered untreatable. However, the high production costs associated with these advanced treatments pose a significant barrier to their widespread adoption. Automation emerges
The fields of cell and gene therapy have seen remarkable advancements and transformative updates over the past few years. As biotechnology companies strive to innovate and deliver groundbreaking solutions, significant milestones have been achieved, fostering hope and optimism for addressing some of
In an era marked by rapid advancements in medical technology, ensuring the safety and efficacy of medical devices remains paramount. The Food and Drug Administration (FDA) has been working diligently on developing a postmarket surveillance system, driven by a 2012 federal law aimed at reducing the
Breas Medical has issued a significant correction involving their Vivo 45 LS ventilators, addressing potential formaldehyde exposure risks. This action impacts over 8,000 devices and comes after findings indicated that under specific conditions, patients could be exposed to harmful levels of
The U.S. pharmaceutical sector faces a critical juncture. With a heavy reliance on Chinese manufacturing for generic drugs and active pharmaceutical ingredients (APIs), the industry finds itself vulnerable. The BIOSECURE Act aims to address these vulnerabilities by reducing or eliminating
Data breaches in the healthcare industry have become an alarming trend. The surge in digital healthcare services and data consolidation has made patient information extremely vulnerable. Understanding the dynamics of data breaches, their legal ramifications, and effective mitigation strategies is
